232 related articles for article (PubMed ID: 24903533)
1. Design, synthesis and evaluation of rhodanine derivatives as aldose reductase inhibitors.
Agrawal YP; Agrawal MY; Gupta AK
Chem Biol Drug Des; 2015 Feb; 85(2):172-80. PubMed ID: 24903533
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and biological evaluation of new epalrestat analogues as aldose reductase inhibitors (ARIs).
Reddy TN; Ravinder M; Bagul P; Ravikanti K; Bagul C; Nanubolu JB; Srinivas K; Banerjee SK; Rao VJ
Eur J Med Chem; 2014 Jan; 71():53-66. PubMed ID: 24275248
[TBL] [Abstract][Full Text] [Related]
3. In vitro studies of potent aldose reductase inhibitors: Synthesis, characterization, biological evaluation and docking analysis of rhodanine-3-hippuric acid derivatives.
Celestina SK; Sundaram K; Ravi S
Bioorg Chem; 2020 Apr; 97():103640. PubMed ID: 32086051
[TBL] [Abstract][Full Text] [Related]
4. Quinazolinone-based rhodanine-3-acetic acids as potent aldose reductase inhibitors: Synthesis, functional evaluation and molecular modeling study.
El-Sayed S; Metwally K; El-Shanawani AA; Abdel-Aziz LM; El-Rashedy AA; Soliman MES; Quattrini L; Coviello V; la Motta C
Bioorg Med Chem Lett; 2017 Oct; 27(20):4760-4764. PubMed ID: 28935265
[TBL] [Abstract][Full Text] [Related]
5. (4-Oxo-2-thioxothiazolidin-3-yl)acetic acids as potent and selective aldose reductase inhibitors.
Kucerova-Chlupacova M; Halakova D; Majekova M; Treml J; Stefek M; Soltesova Prnova M
Chem Biol Interact; 2020 Dec; 332():109286. PubMed ID: 33038328
[TBL] [Abstract][Full Text] [Related]
6. Epalrestat, an Aldose Reductase Inhibitor Prevents Glucose-Induced Toxicity in Human Retinal Pigment Epithelial Cells In Vitro.
Senthilkumari S; Sharmila R; Chidambaranathan G; Vanniarajan A
J Ocul Pharmacol Ther; 2017; 33(1):34-41. PubMed ID: 27835059
[TBL] [Abstract][Full Text] [Related]
7. Docking and molecular dynamics studies toward the binding of new natural phenolic marine inhibitors and aldose reductase.
Wang Z; Ling B; Zhang R; Suo Y; Liu Y; Yu Z; Liu C
J Mol Graph Model; 2009 Sep; 28(2):162-9. PubMed ID: 19616461
[TBL] [Abstract][Full Text] [Related]
8. Ranirestat has a stronger inhibitory activity on aldose reductase and suppresses inflammatory reactions in high glucose-exposed endothelial cells.
Ishibashi Y; Matsui T; Matsumoto T; Kato H; Yamagishi S
Diab Vasc Dis Res; 2016 Jul; 13(4):312-5. PubMed ID: 27190083
[TBL] [Abstract][Full Text] [Related]
9. Novel synthesis of nitro-quinoxalinone derivatives as aldose reductase inhibitors.
Hussain S; Parveen S; Qin X; Hao X; Zhang S; Chen X; Zhu C; Ma B
Bioorg Med Chem Lett; 2014 May; 24(9):2086-9. PubMed ID: 24726808
[TBL] [Abstract][Full Text] [Related]
10. Novel rhodanine based inhibitors of aldose reductase of non-acidic nature with p-hydroxybenzylidene functional group.
Kratky M; Sramel P; Bodo P; Prnova MS; Kovacikova L; Majekova M; Vinsova J; Stefek M
Eur J Med Chem; 2023 Jan; 246():114922. PubMed ID: 36455357
[TBL] [Abstract][Full Text] [Related]
11. Molecular modeling studies of the binding modes of aldose reductase inhibitors at the active site of human aldose reductase.
Lee YS; Chen Z; Kador PF
Bioorg Med Chem; 1998 Oct; 6(10):1811-9. PubMed ID: 9839011
[TBL] [Abstract][Full Text] [Related]
12. Structure-activity relationships studies of quinoxalinone derivatives as aldose reductase inhibitors.
Hussain S; Parveen S; Hao X; Zhang S; Wang W; Qin X; Yang Y; Chen X; Zhu S; Zhu C; Ma B
Eur J Med Chem; 2014 Jun; 80():383-92. PubMed ID: 24793885
[TBL] [Abstract][Full Text] [Related]
13. Induced fit docking, pharmacophore modeling, and molecular dynamic simulations on thiazolidinedione derivatives to explore key interactions with Tyr48 in polyol pathway.
Vijjulatha M; Lingala Y; Merugu RT
J Mol Model; 2014 Jul; 20(7):2348. PubMed ID: 24974084
[TBL] [Abstract][Full Text] [Related]
14. Urinary sorbitol measurement and the effect of an aldose reductase inhibitor on its concentration in the diabetic state.
Nakano I; Tsugawa T; Shinohara R; Watanabe F; Fujita T; Nagata M; Kato T; Himeno Y; Kobayashi T; Fujiwara K; Nagata M; Itoh M; Nagasaka A
J Diabetes Complications; 2003; 17(6):337-42. PubMed ID: 14583178
[TBL] [Abstract][Full Text] [Related]
15. Coumarin-thiazole and -oxadiazole derivatives: Synthesis, bioactivity and docking studies for aldose/aldehyde reductase inhibitors.
Ibrar A; Tehseen Y; Khan I; Hameed A; Saeed A; Furtmann N; Bajorath J; Iqbal J
Bioorg Chem; 2016 Oct; 68():177-86. PubMed ID: 27544072
[TBL] [Abstract][Full Text] [Related]
16. Kinetics and molecular docking studies of an anti-diabetic complication inhibitor fucosterol from edible brown algae Eisenia bicyclis and Ecklonia stolonifera.
Jung HA; Islam MN; Lee CM; Oh SH; Lee S; Jung JH; Choi JS
Chem Biol Interact; 2013 Oct; 206(1):55-62. PubMed ID: 23994501
[TBL] [Abstract][Full Text] [Related]
17. Kinetics and molecular docking studies of kaempferol and its prenylated derivatives as aldose reductase inhibitors.
Jung HA; Moon HE; Oh SH; Kim BW; Sohn HS; Choi JS
Chem Biol Interact; 2012 May; 197(2-3):110-8. PubMed ID: 22543015
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and biological evaluation of some new pyrazoline substituted benzenesulfonylurea/thiourea derivatives as anti-hyperglycaemic agents and aldose reductase inhibitors.
Ovais S; Pushpalatha H; Reddy GB; Rathore P; Bashir R; Yaseen S; Dheyaa A; Yaseen R; Tanwar O; Akthar M; Samim M; Javed K
Eur J Med Chem; 2014 Jun; 80():209-17. PubMed ID: 24780598
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, induced-fit docking investigations, and in vitro aldose reductase inhibitory activity of non-carboxylic acid containing 2,4-thiazolidinedione derivatives.
Maccari R; Ottanà R; Ciurleo R; Rakowitz D; Matuszczak B; Laggner C; Langer T
Bioorg Med Chem; 2008 Jun; 16(11):5840-52. PubMed ID: 18492610
[TBL] [Abstract][Full Text] [Related]
20. Alkaloids as aldose reductase inhibitors, with special reference to berberine.
Gupta S; Singh N; Jaggi AS
J Altern Complement Med; 2014 Mar; 20(3):195-205. PubMed ID: 24236461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
